NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 279 filers reported holding NEOGENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,900 | -46.0% | 3,000 | -29.4% | 0.03% | -39.2% |
| Q2 2023 | $68,298 | +30.8% | 4,250 | +41.7% | 0.05% | +24.4% |
| Q1 2023 | $52,230 | +76.6% | 3,000 | -6.2% | 0.04% | +86.4% |
| Q4 2022 | $29,568 | +28.6% | 3,200 | +18.5% | 0.02% | +10.0% |
| Q3 2022 | $23,000 | +4.5% | 2,700 | 0.0% | 0.02% | +11.1% |
| Q2 2022 | $22,000 | +46.7% | 2,700 | +125.0% | 0.02% | +80.0% |
| Q1 2022 | $15,000 | -63.4% | 1,200 | 0.0% | 0.01% | -61.5% |
| Q4 2021 | $41,000 | -71.5% | 1,200 | -59.8% | 0.03% | -75.5% |
| Q3 2021 | $144,000 | +15.2% | 2,988 | +8.0% | 0.11% | +15.2% |
| Q2 2021 | $125,000 | +594.4% | 2,767 | +641.8% | 0.09% | +557.1% |
| Q1 2021 | $18,000 | +5.9% | 373 | +18.0% | 0.01% | -6.7% |
| Q4 2020 | $17,000 | -79.5% | 316 | -85.9% | 0.02% | -80.0% |
| Q3 2020 | $83,000 | +1085.7% | 2,249 | +848.9% | 0.08% | +837.5% |
| Q2 2020 | $7,000 | – | 237 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,612,363 | $55,014,000 | 24.06% |
| PERKINS CAPITAL MANAGEMENT INC | 155,550 | $5,307,000 | 3.58% |
| First Light Asset Management, LLC | 763,907 | $26,065,000 | 1.87% |
| Bullseye Asset Management LLC | 108,054 | $3,617,000 | 1.44% |
| Ranger Investment Management | 756,380 | $25,808,000 | 1.41% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,006,088 | $34,328,000 | 1.21% |
| EMERALD ADVISERS, LLC | 885,436 | $30,211,000 | 1.12% |
| Granite Investment Partners, LLC | 963,187 | $32,864,000 | 0.96% |
| Nicholas Investment Partners, LP | 428,378 | $14,616,000 | 0.92% |
| Redwood Investments, LLC | 335,054 | $11,432,000 | 0.90% |